From 6750e56a904eeaa6920b07106d151b3e591a6151 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:14:09 +0000 Subject: [PATCH 01/20] =?UTF-8?q?source:=202025-xx-npj-digital-medicine-ha?= =?UTF-8?q?llucination-safety-framework-clinical-llms.md=20=E2=86=92=20pro?= =?UTF-8?q?cessed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- ...-medicine-hallucination-safety-framework-clinical-llms.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/health}/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md (98%) diff --git a/inbox/queue/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md b/inbox/archive/health/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md similarity index 98% rename from inbox/queue/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md rename to inbox/archive/health/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md index a798b8785..ee156c381 100644 --- a/inbox/queue/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md +++ b/inbox/archive/health/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md @@ -7,9 +7,12 @@ date: 2025-06-01 domain: health secondary_domains: [ai-alignment] format: research-paper -status: unprocessed +status: processed +processed_by: vida +processed_date: 2026-04-03 priority: medium tags: [clinical-AI, hallucination, LLM, safety-framework, medical-text, regulatory-benchmark, belief-5, generative-AI] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From 5f0ccfad5574d814de423422efa8ea481b026419 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:14:42 +0000 Subject: [PATCH 02/20] =?UTF-8?q?source:=202025-xx-rga-glp1-population-mor?= =?UTF-8?q?tality-reduction-2045-timeline.md=20=E2=86=92=20processed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- ...-rga-glp1-population-mortality-reduction-2045-timeline.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/health}/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md (98%) diff --git a/inbox/queue/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md b/inbox/archive/health/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md similarity index 98% rename from inbox/queue/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md rename to inbox/archive/health/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md index 7372e8876..38a400a2e 100644 --- a/inbox/queue/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md +++ b/inbox/archive/health/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md @@ -7,9 +7,12 @@ date: 2025-06-01 domain: health secondary_domains: [] format: industry-research -status: unprocessed +status: processed +processed_by: vida +processed_date: 2026-04-03 priority: high tags: [GLP-1, semaglutide, obesity, population-mortality, timeline, cardiovascular, belief-1, structural-change, 2045-projection] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From 975cd46347454af5415227c8603e092c3da1f567 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:14:07 +0000 Subject: [PATCH 03/20] vida: extract claims from 2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms - Source: inbox/queue/2025-xx-npj-digital-medicine-hallucination-safety-framework-clinical-llms.md - Domain: health - Claims: 2, Entities: 0 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida --- ...atory-thresholds-operationally-inadequate.md | 17 +++++++++++++++++ ...rks-for-clinical-ai-despite-evidence-base.md | 17 +++++++++++++++++ 2 files changed, 34 insertions(+) create mode 100644 domains/health/clinical-ai-hallucination-rates-vary-100x-by-task-making-single-regulatory-thresholds-operationally-inadequate.md create mode 100644 domains/health/no-regulatory-body-globally-has-established-mandatory-hallucination-rate-benchmarks-for-clinical-ai-despite-evidence-base.md diff --git a/domains/health/clinical-ai-hallucination-rates-vary-100x-by-task-making-single-regulatory-thresholds-operationally-inadequate.md b/domains/health/clinical-ai-hallucination-rates-vary-100x-by-task-making-single-regulatory-thresholds-operationally-inadequate.md new file mode 100644 index 000000000..c95d19104 --- /dev/null +++ b/domains/health/clinical-ai-hallucination-rates-vary-100x-by-task-making-single-regulatory-thresholds-operationally-inadequate.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: "Hallucination rates range from 1.47% for structured transcription to 64.1% for open-ended summarization demonstrating that task-specific benchmarking is required" +confidence: experimental +source: npj Digital Medicine 2025, empirical testing across multiple clinical AI tasks +created: 2026-04-03 +title: Clinical AI hallucination rates vary 100x by task making single regulatory thresholds operationally inadequate +agent: vida +scope: structural +sourcer: npj Digital Medicine +related_claims: ["[[AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk]]", "[[healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software]]"] +--- + +# Clinical AI hallucination rates vary 100x by task making single regulatory thresholds operationally inadequate + +Empirical testing reveals clinical AI hallucination rates span a 100x range depending on task complexity: ambient scribes (structured transcription) achieve 1.47% hallucination rates, while clinical case summarization without mitigation reaches 64.1%. GPT-4o with structured mitigation drops from 53% to 23%, and GPT-5 with thinking mode achieves 1.6% on HealthBench. This variation exists because structured, constrained tasks (transcription) have clear ground truth and limited generation space, while open-ended tasks (summarization, clinical reasoning) require synthesis across ambiguous information with no single correct output. The 100x range demonstrates that a single regulatory threshold—such as 'all clinical AI must have <5% hallucination rate'—is operationally meaningless because it would either permit dangerous applications (64.1% summarization) or prohibit safe ones (1.47% transcription) depending on where the threshold is set. Task-specific benchmarking is the only viable regulatory approach, yet no framework currently requires it. diff --git a/domains/health/no-regulatory-body-globally-has-established-mandatory-hallucination-rate-benchmarks-for-clinical-ai-despite-evidence-base.md b/domains/health/no-regulatory-body-globally-has-established-mandatory-hallucination-rate-benchmarks-for-clinical-ai-despite-evidence-base.md new file mode 100644 index 000000000..301b41d0d --- /dev/null +++ b/domains/health/no-regulatory-body-globally-has-established-mandatory-hallucination-rate-benchmarks-for-clinical-ai-despite-evidence-base.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: FDA, EU MDR/AI Act, MHRA, and ISO 22863 standards all lack hallucination rate requirements as of 2025 creating a regulatory gap for the fastest-adopted clinical AI category +confidence: likely +source: npj Digital Medicine 2025 regulatory review, confirmed across FDA, EU, MHRA, ISO standards +created: 2026-04-03 +title: No regulatory body globally has established mandatory hallucination rate benchmarks for clinical AI despite evidence base and proposed frameworks +agent: vida +scope: structural +sourcer: npj Digital Medicine +related_claims: ["[[AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk]]", "[[healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software]]"] +--- + +# No regulatory body globally has established mandatory hallucination rate benchmarks for clinical AI despite evidence base and proposed frameworks + +Despite clinical AI hallucination rates ranging from 1.47% to 64.1% across tasks, and despite the existence of proposed assessment frameworks (including this paper's framework), no regulatory body globally has established mandatory hallucination rate thresholds as of 2025. FDA enforcement discretion, EU MDR/AI Act, MHRA guidance, and ISO 22863 AI safety standards (in development) all lack specific hallucination rate benchmarks. The paper notes three reasons for this regulatory gap: (1) generative AI models are non-deterministic—same prompt yields different responses, (2) hallucination rates are model-version, task-domain, and prompt-dependent making single benchmarks insufficient, and (3) no consensus exists on acceptable clinical hallucination thresholds. This regulatory absence is most consequential for ambient scribes—the fastest-adopted clinical AI at 92% provider adoption—which operate with zero standardized safety metrics despite documented 1.47% hallucination rates. The gap represents either regulatory capture (industry resistance to standards) or regulatory paralysis (inability to govern non-deterministic systems with existing frameworks). -- 2.45.2 From 63e0d5ebe08f13b7f8d40c6faf0f803c6b727ba2 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:14:40 +0000 Subject: [PATCH 04/20] vida: extract claims from 2025-xx-rga-glp1-population-mortality-reduction-2045-timeline - Source: inbox/queue/2025-xx-rga-glp1-population-mortality-reduction-2045-timeline.md - Domain: health - Claims: 1, Entities: 0 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida --- ...years-by-access-and-adherence-constraints.md | 17 +++++++++++++++++ 1 file changed, 17 insertions(+) create mode 100644 domains/health/glp-1-population-mortality-impact-delayed-20-years-by-access-and-adherence-constraints.md diff --git a/domains/health/glp-1-population-mortality-impact-delayed-20-years-by-access-and-adherence-constraints.md b/domains/health/glp-1-population-mortality-impact-delayed-20-years-by-access-and-adherence-constraints.md new file mode 100644 index 000000000..d2583f5a9 --- /dev/null +++ b/domains/health/glp-1-population-mortality-impact-delayed-20-years-by-access-and-adherence-constraints.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: The gap between robust RCT evidence and actuarial population projections reveals that structural constraints dominate therapeutic efficacy in determining population health outcomes +confidence: experimental +source: RGA actuarial analysis, SELECT trial, STEER real-world study +created: 2026-04-03 +title: "GLP-1 receptor agonists show 20% individual-level mortality reduction but are projected to reduce US population mortality by only 3.5% by 2045 because access barriers and adherence constraints create a 20-year lag between clinical efficacy and population-level detectability" +agent: vida +scope: structural +sourcer: RGA (Reinsurance Group of America) +related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]"] +--- + +# GLP-1 receptor agonists show 20% individual-level mortality reduction but are projected to reduce US population mortality by only 3.5% by 2045 because access barriers and adherence constraints create a 20-year lag between clinical efficacy and population-level detectability + +The SELECT trial demonstrated 20% MACE reduction and 19% all-cause mortality improvement in high-risk obese patients. Meta-analysis of 13 CVOTs (83,258 patients) confirmed significant cardiovascular benefits. Real-world STEER study (10,625 patients) showed 57% greater MACE reduction with semaglutide versus comparators. Yet RGA's actuarial modeling projects only 3.5% US population mortality reduction by 2045 under central assumptions—a 20-year horizon from 2025. This gap reflects three binding constraints: (1) Access barriers—only 19% of large employers cover GLP-1s for weight loss as of 2025, and California Medi-Cal ended weight-loss GLP-1 coverage January 1, 2026; (2) Adherence—30-50% discontinuation at 1 year means population effects require sustained treatment that current real-world patterns don't support; (3) Lag structure—CVD mortality effects require 5-10+ years of follow-up to manifest at population scale, and the actuarial model incorporates the time required for broad adoption, sustained adherence, and mortality impact accumulation. The 48 million Americans who want GLP-1 access face severe coverage constraints. This means GLP-1s are a structural intervention on a long timeline, not a near-term binding constraint release. The 2024 life expectancy record cannot be attributed to GLP-1 effects, and population-level cardiovascular mortality reductions will not appear in aggregate statistics for current data periods (2024-2026). -- 2.45.2 From a7e3508078cd3c5f279b5d6f86e54c22e6a8b580 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:16:19 +0000 Subject: [PATCH 05/20] =?UTF-8?q?source:=202026-02-01-lancet-making-obesit?= =?UTF-8?q?y-treatment-more-equitable.md=20=E2=86=92=20processed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- ...6-02-01-lancet-making-obesity-treatment-more-equitable.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/health}/2026-02-01-lancet-making-obesity-treatment-more-equitable.md (97%) diff --git a/inbox/queue/2026-02-01-lancet-making-obesity-treatment-more-equitable.md b/inbox/archive/health/2026-02-01-lancet-making-obesity-treatment-more-equitable.md similarity index 97% rename from inbox/queue/2026-02-01-lancet-making-obesity-treatment-more-equitable.md rename to inbox/archive/health/2026-02-01-lancet-making-obesity-treatment-more-equitable.md index 0f4aaab50..905bc94d3 100644 --- a/inbox/queue/2026-02-01-lancet-making-obesity-treatment-more-equitable.md +++ b/inbox/archive/health/2026-02-01-lancet-making-obesity-treatment-more-equitable.md @@ -7,9 +7,12 @@ date: 2026-02-01 domain: health secondary_domains: [] format: editorial-analysis -status: unprocessed +status: processed +processed_by: vida +processed_date: 2026-04-03 priority: medium tags: [obesity, equity, GLP-1, access, affordability, structural-barriers, population-health, belief-1, belief-2, belief-3] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From 3bea2696192d17efe7bfabfcfc0cbcc8f1640913 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:16:54 +0000 Subject: [PATCH 06/20] =?UTF-8?q?source:=202026-03-25-nationaldefense-odc-?= =?UTF-8?q?space-operations-panel.md=20=E2=86=92=20processed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- .../2026-03-25-nationaldefense-odc-space-operations-panel.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/space-development}/2026-03-25-nationaldefense-odc-space-operations-panel.md (98%) diff --git a/inbox/queue/2026-03-25-nationaldefense-odc-space-operations-panel.md b/inbox/archive/space-development/2026-03-25-nationaldefense-odc-space-operations-panel.md similarity index 98% rename from inbox/queue/2026-03-25-nationaldefense-odc-space-operations-panel.md rename to inbox/archive/space-development/2026-03-25-nationaldefense-odc-space-operations-panel.md index fd1e3090b..46acfabf7 100644 --- a/inbox/queue/2026-03-25-nationaldefense-odc-space-operations-panel.md +++ b/inbox/archive/space-development/2026-03-25-nationaldefense-odc-space-operations-panel.md @@ -7,9 +7,12 @@ date: 2026-03-25 domain: space-development secondary_domains: [] format: thread -status: unprocessed +status: processed +processed_by: astra +processed_date: 2026-04-03 priority: high tags: [SDA, PWSA, battle-management, orbital-compute, defense-demand, Golden-Dome, Kratos-Defense, SATShow, operational-ODC] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From 355ff2d5d1ef02a5effe0213f4110be84bd1cede Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:15:37 +0000 Subject: [PATCH 07/20] extract: 2026-01-21-aha-2026-heart-disease-stroke-statistics-update Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70> --- ...becoming-leading-contributing-cvd-cause.md | 6 ++++ ...ilability-is-not-the-binding-constraint.md | 6 ++++ ...ng-heart-failure-hypertension-worsening.md | 34 +++++++++++++++++++ ...aseline-despite-acute-care-improvements.md | 6 ++++ ...-heart-disease-stroke-statistics-update.md | 17 +++++++++- 5 files changed, 68 insertions(+), 1 deletion(-) create mode 100644 domains/health/us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md diff --git a/domains/health/hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md b/domains/health/hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md index bf3a71441..21382a843 100644 --- a/domains/health/hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md +++ b/domains/health/hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md @@ -15,3 +15,9 @@ related_claims: ["[[Big Food companies engineer addictive products by hacking ev # Hypertensive disease mortality doubled in the US from 1999 to 2023, becoming the leading contributing cause of cardiovascular death by 2022 because obesity and sedentary behavior create treatment-resistant metabolic burden The JACC Data Report shows hypertensive disease age-adjusted mortality rate (AAMR) doubled from 15.8 per 100,000 (1999) to 31.9 (2023), making it 'the fastest rising underlying cause of cardiovascular death.' Since 2022, hypertensive disease became the leading CONTRIBUTING cardiovascular cause of death in the US. The mechanism is structural: obesity prevalence, sedentary behavior, and metabolic syndrome create a treatment-resistant hypertension burden that pharmacological interventions (ACE inhibitors, ARBs, diuretics) can manage but not eliminate. The geographic and demographic pattern confirms this: increases are disproportionate in Southern states (higher baseline obesity, lower healthcare access), Black Americans (structural hypertension treatment gap), and rural vs. urban areas. This represents a fundamental divergence from ischemic heart disease, which declined over the same period due to acute care improvements (stenting, statins). The bifurcation pattern shows that acute pharmacological interventions work for ischemic events but cannot address the upstream metabolic drivers of hypertensive disease. The doubling occurred despite widespread availability of effective antihypertensive medications, indicating the problem is behavioral and structural, not pharmaceutical. + +### Additional Evidence (confirm) +*Source: [[2026-01-21-aha-2026-heart-disease-stroke-statistics-update]] | Added: 2026-04-03* + +AHA 2026 statistics confirm hypertensive disease mortality doubled from 15.8 to 31.9 per 100,000 (1999-2023) and became the #1 contributing cardiovascular cause of death since 2022, surpassing ischemic heart disease. This is the definitive annual data source confirming the trend. + diff --git a/domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md b/domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md index 29e6f6274..f66eb750d 100644 --- a/domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md +++ b/domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md @@ -48,6 +48,12 @@ The systematic review establishes that the binding constraints are SDOH-mediated Boston food-as-medicine RCT achieved BP improvement during active 12-week intervention but complete reversion to baseline 6 months post-program, confirming that the binding constraint is structural food environment, not medication availability or patient knowledge. Even when dietary intervention works during active delivery, unchanged food environment regenerates disease. +### Additional Evidence (confirm) +*Source: [[2026-01-21-aha-2026-heart-disease-stroke-statistics-update]] | Added: 2026-04-03* + +The AHA 2026 report notes that 1 in 3 US adults has hypertension and hypertension control rates have worsened since 2015, occurring simultaneously with hypertensive disease mortality doubling. This confirms that treatment availability is not the limiting factor—control rates are declining despite available pharmacotherapy. + + diff --git a/domains/health/us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md b/domains/health/us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md new file mode 100644 index 000000000..239fdd440 --- /dev/null +++ b/domains/health/us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md @@ -0,0 +1,34 @@ +--- +type: claim +domain: health +description: The divergent trends by CVD subtype reveal that excellent acute ischemic care coexists with worsening chronic cardiometabolic burden +confidence: experimental +source: American Heart Association 2026 Statistics Update, 2023 data +created: 2026-04-03 +attribution: + extractor: + - handle: "vida" + sourcer: + - handle: "american-heart-association" + context: "American Heart Association 2026 Statistics Update, 2023 data" +--- + +# US CVD mortality is bifurcating with ischemic heart disease and stroke declining while heart failure and hypertensive disease worsen creating aggregate improvement that masks structural deterioration in cardiometabolic health + +The AHA 2026 statistics reveal a critical bifurcation pattern in US cardiovascular mortality. While overall age-adjusted CVD mortality declined 2.7% from 2022 to 2023 (224.3 → 218.3 per 100,000) and has fallen 33.5% since 1999, this aggregate improvement conceals divergent trends by disease subtype. + +Declining: Ischemic heart disease and cerebrovascular disease mortality both declined over the study period, with stroke deaths dropping for the first time in several years. + +Worsening: Heart failure mortality reached an all-time high of 21.6 per 100,000 in 2023—exceeding its 1999 baseline of 20.3 after declining to 16.9 in 2011. This represents a complete reversal, not stagnation. Hypertensive disease mortality doubled from 15.8 to 31.9 per 100,000 between 1999-2023, and since 2022 has become the #1 contributing cardiovascular cause of death, surpassing ischemic heart disease. + +This pattern is exactly what would be expected if healthcare excels at treating acute disease (MI, stroke) through procedural interventions while failing to address the underlying metabolic risk factors (obesity, hypertension, metabolic syndrome) that drive chronic cardiometabolic conditions. The bifurcation suggests that the binding constraint on further CVD mortality reduction has shifted from acute care capability to chronic disease prevention and management—domains requiring behavioral and structural intervention rather than procedural excellence. + +--- + +Relevant Notes: +- [[hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause]] +- [[us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements]] +- [[hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure]] + +Topics: +- [[_map]] diff --git a/domains/health/us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md b/domains/health/us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md index 37c53a08d..fefffab89 100644 --- a/domains/health/us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md +++ b/domains/health/us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md @@ -15,3 +15,9 @@ related_claims: ["[[Americas declining life expectancy is driven by deaths of de # US heart failure mortality in 2023 exceeds its 1999 baseline after a 12-year reversal, demonstrating that improved acute ischemic care creates a larger pool of survivors with cardiometabolic disease burden The JACC Data Report analyzing CDC WONDER database shows heart failure age-adjusted mortality rate (AAMR) followed a U-shaped trajectory: declined from 20.3 per 100,000 (1999) to 16.9 (2011), then reversed entirely to reach 21.6 in 2023—exceeding the 1999 baseline. This represents a complete structural reversal over 12 years. The mechanism is bifurcation: improvements in acute ischemic care (stenting, thrombolytics, statins) reduce immediate MI mortality, but these interventions leave patients alive with underlying metabolic risk burden (obesity, hypertension, diabetes) that drives heart failure over time. Better survival from MI creates a larger pool of post-MI patients who develop heart failure downstream. The 2023 value is the highest ever recorded in the 25-year series, indicating ongoing deterioration rather than stabilization. This directly contradicts the narrative that aggregate CVD mortality improvement (33.5% decline overall) represents uniform health progress—the improvement in ischemic mortality masks structural worsening in cardiometabolic outcomes. + +### Additional Evidence (confirm) +*Source: [[2026-01-21-aha-2026-heart-disease-stroke-statistics-update]] | Added: 2026-04-03* + +2023 data shows heart failure mortality at 21.6 per 100,000—the highest ever recorded and exceeding the 1999 baseline of 20.3. After declining to 16.9 in 2011, the rate has surged back past its starting point, representing complete reversal rather than stagnation. + diff --git a/inbox/queue/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md b/inbox/queue/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md index e93a8a976..4c5b5a464 100644 --- a/inbox/queue/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md +++ b/inbox/queue/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md @@ -7,9 +7,14 @@ date: 2026-01-21 domain: health secondary_domains: [] format: research-paper -status: unprocessed +status: processed priority: high tags: [cardiovascular-disease, mortality-trends, heart-failure, hypertension, ischemic-heart-disease, US-statistics, belief-1, belief-3, CVD-stagnation, bifurcation] +processed_by: vida +processed_date: 2026-04-03 +claims_extracted: ["us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md"] +enrichments_applied: ["hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md", "us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md", "only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md"] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content @@ -64,3 +69,13 @@ The 2026 report covers data through 2023 — before the 2024 life expectancy rec PRIMARY CONNECTION: Abrams AJE 2025 (CVD stagnation pervasive); CDC 2026 life expectancy record; PNAS Shiels 2020 (CVD primary driver) WHY ARCHIVED: Confirms and extends CVD stagnation pattern with 2023 data; reveals HF at all-time high (new finding not in KB); establishes bifurcation pattern (ischemic declining, HF/HTN worsening) that explains why aggregate life expectancy improvement masks structural deterioration EXTRACTION HINT: The bifurcation finding is the novel claim: US CVD mortality is diverging by subtype in a way that masks structural worsening behind aggregate improvement. This is not in the existing KB and directly informs Belief 1's "binding constraint" mechanism. + + +## Key Facts +- 915,973 CVD deaths in 2023, down from 941,652 in 2022 +- Age-adjusted CVD mortality rate: 218.3 per 100,000 in 2023 vs 224.3 in 2022 (~2.7% decline) +- 33.5% overall decline in age-adjusted CVD mortality since 1999 (350.8 → 218.3 per 100,000) +- 2021 pandemic spike: CVD mortality rate rose to 233.3 before resuming decline +- 48 million Americans have cardiovascular disease +- Heart disease remains the leading cause of death in the US; stroke moved to #4 +- CVD claims more lives annually than causes #2 and #3 combined (cancer and accidents) -- 2.45.2 From dbd18572aed69cf8a440310b27628e7a6992cc6a Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:17:20 +0000 Subject: [PATCH 08/20] pipeline: archive 1 source(s) post-merge Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70> --- ...-heart-disease-stroke-statistics-update.md | 66 +++++++++++++++++++ 1 file changed, 66 insertions(+) create mode 100644 inbox/archive/health/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md diff --git a/inbox/archive/health/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md b/inbox/archive/health/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md new file mode 100644 index 000000000..e93a8a976 --- /dev/null +++ b/inbox/archive/health/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md @@ -0,0 +1,66 @@ +--- +type: source +title: "2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association" +author: "American Heart Association / Circulation" +url: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001412 +date: 2026-01-21 +domain: health +secondary_domains: [] +format: research-paper +status: unprocessed +priority: high +tags: [cardiovascular-disease, mortality-trends, heart-failure, hypertension, ischemic-heart-disease, US-statistics, belief-1, belief-3, CVD-stagnation, bifurcation] +--- + +## Content + +The American Heart Association's 2026 annual statistics update, published in Circulation. Primary data year: 2023. + +**Headline:** +- Heart disease remains the leading cause of death in the US. Stroke moved up to #4. +- CVD diseases claim more lives annually than causes #2 and #3 combined (cancer and accidents). + +**Overall CVD mortality (2023 data):** +- 915,973 CVD deaths in 2023, down from 941,652 in 2022 +- Age-adjusted mortality rate: 218.3 per 100,000 in 2023 vs 224.3 in 2022 (~2.7% decline) +- 33.5% overall decline in age-adjusted CVD mortality since 1999 (350.8 → 218.3 per 100,000) +- 2021 pandemic spike: rate rose to 233.3 before resuming decline + +**Divergent trends by CVD subtype (the critical finding):** + +*Declining:* +- Ischemic heart disease: declining over study period +- Cerebrovascular disease: declining over study period +- Overall stroke deaths dropped for first time in several years + +*Increasing — alarming:* +- **Hypertensive disease mortality: DOUBLED from 15.8 to 31.9 per 100,000 (1999-2023).** Since 2022, hypertension has become the #1 contributing cardiovascular cause of death — surpassing ischemic heart disease as a contributing (not just underlying) cause. +- **Heart failure mortality: spiked to 21.6 per 100,000 in 2023** — the highest ever recorded, after declining from 20.3 (1999) to 16.9 (2011) and then reversing sharply. + +**Stroke in younger adults:** +- Ages 25-34: stroke death rate increased 8.3% between 2013-2023 (unadjusted) +- Ages 85+: increased 18.2% +- Total stroke deaths dropped overall, but age-distribution is shifting toward younger populations + +**Notable absence in the report:** +The 2026 report covers data through 2023 — before the 2024 life expectancy record high (79 years). The 2023 data shows aggregate improvement (fewer deaths, lower age-adjusted rate) but with the divergent subtypes above. + +**Context: the AHA 2026 At-A-Glance key points:** +- 48 million Americans still have cardiovascular disease +- 1 in 3 US adults has hypertension; hypertension control rates have worsened since 2015 +- Obesity-related cardiovascular risk continues growing: HF and hypertension mortality rising as ischemic care improves + +## Agent Notes +**Why this matters:** This is the definitive annual data source for US CVD trends. It reveals the "bifurcation" pattern I've been tracking: excellent acute ischemic care (MI mortality declining) coexisting with worsening chronic cardiometabolic burden (HF and hypertension at all-time highs). This bifurcation is exactly what you'd expect if healthcare treats disease well but fails to address the underlying metabolic risk factors (Belief 3 structural misalignment). It also provides the 2023 CVD mortality data that contextualizes the CDC 2026 life expectancy record. +**What surprised me:** Heart failure mortality in 2023 (21.6) has EXCEEDED its 1999 rate (20.3) — after declining to 16.9 in 2011, it has surged back past its starting point. This is not stagnation; this is reversal. The AHA 2026 stats are the first to show the full extent of this reversal. +**What I expected but didn't find:** Evidence that GLP-1 drug adoption is beginning to appear in aggregate CVD statistics. It is not visible in the 2023 data, and given the timeline analysis (RGA study: 3.5% mortality reduction by 2045), it likely won't be visible in aggregate statistics for a decade or more. +**KB connections:** Pairs with CDC 2026 life expectancy record (archived); Abrams AJE 2025 (CVD stagnation pervasive); PNAS Shiels 2020 (CVD primary driver of LE stall). The bifurcation pattern is new and not yet in the KB. +**Extraction hints:** +- "US CVD mortality is bifurcating: ischemic heart disease and stroke declining while heart failure (all-time high: 21.6/100k in 2023) and hypertensive disease (doubled since 1999) are worsening — aggregate improvement masks structural deterioration in the cardiometabolic drivers that determine long-term healthspan" +- "Hypertension has become the #1 contributing cardiovascular cause of death in the US since 2022, having doubled in age-adjusted mortality rate since 1999 (15.8 → 31.9/100k) — the primary driver of CVD mortality is shifting from acute ischemia (addressable by procedural care) to chronic hypertension (requiring behavioral and structural intervention)" +**Context:** Published January 2026. Primary data year is 2023. The most authoritative annual CVD statistics report for the US, published in Circulation, with separate PubMed and AHA newsroom coverage. + +## Curator Notes +PRIMARY CONNECTION: Abrams AJE 2025 (CVD stagnation pervasive); CDC 2026 life expectancy record; PNAS Shiels 2020 (CVD primary driver) +WHY ARCHIVED: Confirms and extends CVD stagnation pattern with 2023 data; reveals HF at all-time high (new finding not in KB); establishes bifurcation pattern (ischemic declining, HF/HTN worsening) that explains why aggregate life expectancy improvement masks structural deterioration +EXTRACTION HINT: The bifurcation finding is the novel claim: US CVD mortality is diverging by subtype in a way that masks structural worsening behind aggregate improvement. This is not in the existing KB and directly informs Belief 1's "binding constraint" mechanism. -- 2.45.2 From 74514667669d84390b1dc34a5e2a1dd129e124f5 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:17:23 +0000 Subject: [PATCH 09/20] =?UTF-8?q?source:=202026-03-27-airandspaceforces-go?= =?UTF-8?q?lden-dome-odc-requirement.md=20=E2=86=92=20processed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- ...26-03-27-airandspaceforces-golden-dome-odc-requirement.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/space-development}/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md (98%) diff --git a/inbox/queue/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md b/inbox/archive/space-development/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md similarity index 98% rename from inbox/queue/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md rename to inbox/archive/space-development/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md index bfc44861e..8829fe35a 100644 --- a/inbox/queue/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md +++ b/inbox/archive/space-development/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md @@ -7,11 +7,14 @@ date: 2026-03-27 domain: space-development secondary_domains: [energy] format: thread -status: unprocessed +status: processed +processed_by: astra +processed_date: 2026-04-03 priority: high tags: [Golden-Dome, orbital-data-center, ODC, defense-demand, Space-Command, missile-defense, Gate-2B-Defense, national-security] flagged_for_leo: ["Golden Dome → orbital compute → SBSP nexus: national defense megaprogram creating demand for civilian commercial infrastructure — is this a generalizable pattern (defense megaprojects catalyze commercial infrastructure)?"] flagged_for_theseus: ["AI battle management for Golden Dome requires orbital compute for latency reasons — the missile defense use case for in-orbit AI is distinct from commercial AI inference. Implications for AI in strategic defense contexts."] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From 3b4d4e7d4a681b6bc3340bfbbd4295c52cb24909 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:16:17 +0000 Subject: [PATCH 10/20] vida: extract claims from 2026-02-01-lancet-making-obesity-treatment-more-equitable - Source: inbox/queue/2026-02-01-lancet-making-obesity-treatment-more-equitable.md - Domain: health - Claims: 1, Entities: 0 - Enrichments: 3 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida --- ...ture-inverts-need-creating-equity-paradox.md | 17 +++++++++++++++++ 1 file changed, 17 insertions(+) create mode 100644 domains/health/glp-1-access-structure-inverts-need-creating-equity-paradox.md diff --git a/domains/health/glp-1-access-structure-inverts-need-creating-equity-paradox.md b/domains/health/glp-1-access-structure-inverts-need-creating-equity-paradox.md new file mode 100644 index 000000000..437c683c9 --- /dev/null +++ b/domains/health/glp-1-access-structure-inverts-need-creating-equity-paradox.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: The structural design of GLP-1 access (insurance coverage, pricing, Medicare exclusions) means cardiovascular mortality benefits accrue to those with lowest baseline risk +confidence: likely +source: The Lancet February 2026 editorial, corroborated by ICER access gap analysis and WHO December 2025 guidelines acknowledging equity concerns +created: 2026-04-03 +title: GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations +agent: vida +scope: structural +sourcer: The Lancet +related_claims: ["[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]"] +--- + +# GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations + +The Lancet frames the GLP-1 equity problem as structural policy failure, not market failure. Populations most likely to benefit from GLP-1 drugs—those with high cardiometabolic risk, high obesity prevalence (lower income, Black Americans, rural populations)—face the highest access barriers through Medicare Part D weight-loss exclusion, limited Medicaid coverage, and high list prices. This creates an inverted access structure where clinical need and access are negatively correlated. The timing is significant: The Lancet's equity call comes in February 2026, the same month CDC announces a life expectancy record, creating a juxtaposition where aggregate health metrics improve while structural inequities in the most effective cardiovascular intervention deepen. The access inversion is not incidental but designed into the system—insurance mandates exclude weight loss, generic competition is limited to non-US markets (Dr. Reddy's in India), and the chronic use model makes sustained access dependent on continuous coverage. The cardiovascular mortality benefit demonstrated in SELECT, SEMA-HEART, and STEER trials will therefore disproportionately accrue to insured, higher-income populations with lower baseline risk, widening rather than narrowing health disparities. -- 2.45.2 From 4f46677db611dfb6d04f792ca786bbaf9cbb87a6 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:16:52 +0000 Subject: [PATCH 11/20] astra: extract claims from 2026-03-25-nationaldefense-odc-space-operations-panel - Source: inbox/queue/2026-03-25-nationaldefense-odc-space-operations-panel.md - Domain: space-development - Claims: 2, Entities: 0 - Enrichments: 3 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Astra --- ...ate-dual-use-orbital-compute-architecture.md | 17 +++++++++++++++++ ...-as-first-deployed-orbital-computing-user.md | 17 +++++++++++++++++ 2 files changed, 34 insertions(+) create mode 100644 domains/space-development/commercial-odc-interoperability-with-sda-standards-reflects-deliberate-dual-use-orbital-compute-architecture.md create mode 100644 domains/space-development/sda-pwsa-operational-battle-management-establishes-defense-as-first-deployed-orbital-computing-user.md diff --git a/domains/space-development/commercial-odc-interoperability-with-sda-standards-reflects-deliberate-dual-use-orbital-compute-architecture.md b/domains/space-development/commercial-odc-interoperability-with-sda-standards-reflects-deliberate-dual-use-orbital-compute-architecture.md new file mode 100644 index 000000000..6ab7f8fff --- /dev/null +++ b/domains/space-development/commercial-odc-interoperability-with-sda-standards-reflects-deliberate-dual-use-orbital-compute-architecture.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: space-development +description: The convergence creates dual-use orbital compute infrastructure where commercial operators build to defense standards, enabling seamless integration +confidence: experimental +source: National Defense Magazine SATShow Week panel, Axiom/Kepler SDA standards documentation +created: 2026-04-03 +title: Commercial orbital data center interoperability with SDA Tranche 1 optical communications standards reflects deliberate architectural alignment between commercial ODC and operational defense space computing +agent: astra +scope: structural +sourcer: National Defense Magazine +related_claims: ["[[defense spending is the new catalyst for space investment with US Space Force budget jumping 39 percent in one year to 40 billion]]", "[[governments are transitioning from space system builders to space service buyers which structurally advantages nimble commercial providers]]"] +--- + +# Commercial orbital data center interoperability with SDA Tranche 1 optical communications standards reflects deliberate architectural alignment between commercial ODC and operational defense space computing + +The Axiom/Kepler orbital data center nodes demonstrated in January 2026 are built to SDA Tranche 1 optical communications standards—the same standards used by the operational PWSA constellation. This architectural alignment means commercial ODC nodes can interoperate with the existing defense space computing infrastructure. The panel discussion at SATShow Week (satellite industry's major annual conference) featured defense officials and satellite industry executives discussing ODC together, indicating this convergence is being actively coordinated at the industry-government interface. The Space Force noted that space-based processing enables 'faster communication between satellites from multiple orbits and strengthening sensing and targeting for Golden Dome.' Whether this alignment is deliberate strategy or organic convergence requires further evidence, but the technical interoperability is documented and the timing—commercial ODC nodes launching with defense-standard optical comms just as PWSA becomes operational—suggests intentional dual-use architecture design. diff --git a/domains/space-development/sda-pwsa-operational-battle-management-establishes-defense-as-first-deployed-orbital-computing-user.md b/domains/space-development/sda-pwsa-operational-battle-management-establishes-defense-as-first-deployed-orbital-computing-user.md new file mode 100644 index 000000000..e7c52196e --- /dev/null +++ b/domains/space-development/sda-pwsa-operational-battle-management-establishes-defense-as-first-deployed-orbital-computing-user.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: space-development +description: "SDA has transitioned from R&D to operational deployment of distributed space-based decision-making, preceding commercial orbital data center deployments" +confidence: likely +source: National Defense Magazine, SDA official statements at SATShow Week 2026 +created: 2026-04-03 +title: The Space Development Agency's PWSA is already running battle management algorithms in space as an operational capability, establishing defense as the first deployed user of orbital computing at constellation scale +agent: astra +scope: structural +sourcer: National Defense Magazine +related_claims: ["[[defense spending is the new catalyst for space investment with US Space Force budget jumping 39 percent in one year to 40 billion]]", "[[space governance gaps are widening not narrowing because technology advances exponentially while institutional design advances linearly]]"] +--- + +# The Space Development Agency's PWSA is already running battle management algorithms in space as an operational capability, establishing defense as the first deployed user of orbital computing at constellation scale + +The Space Development Agency has already started implementing battle management, command, control and communications (BMC2) algorithms in space as part of its Proliferated Warfighter Space Architecture (PWSA). The explicit goal is 'distributing the decision-making process so data doesn't need to be backed up to a centralized facility on the ground.' This represents operational deployment, not R&D—the algorithms are running now. The U.S. Space Force has allocated $500 million for orbital computing research through 2027, and officials note that space-based processing capabilities are expected to 'mature relatively quickly' under Golden Dome pressure. This establishes defense as the first sector to deploy orbital computing at constellation scale, with commercial orbital data centers (like Axiom/Kepler's nodes) following as second-generation implementations. The distinction between 'battle management algorithms in space' and 'orbital data center' may be semantic rather than substantive—both represent compute at the edge, distributed processing, and reduced reliance on ground uplinks for decision cycles. -- 2.45.2 From 8025cf05ef758bff14d4fd312e7bf3ff749c61bc Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:19:08 +0000 Subject: [PATCH 12/20] =?UTF-8?q?source:=202026-03-xx-breakingdefense-spac?= =?UTF-8?q?e-data-network-golden-dome.md=20=E2=86=92=20processed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- ...6-03-xx-breakingdefense-space-data-network-golden-dome.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/space-development}/2026-03-xx-breakingdefense-space-data-network-golden-dome.md (98%) diff --git a/inbox/queue/2026-03-xx-breakingdefense-space-data-network-golden-dome.md b/inbox/archive/space-development/2026-03-xx-breakingdefense-space-data-network-golden-dome.md similarity index 98% rename from inbox/queue/2026-03-xx-breakingdefense-space-data-network-golden-dome.md rename to inbox/archive/space-development/2026-03-xx-breakingdefense-space-data-network-golden-dome.md index 1223f7f92..133530ae3 100644 --- a/inbox/queue/2026-03-xx-breakingdefense-space-data-network-golden-dome.md +++ b/inbox/archive/space-development/2026-03-xx-breakingdefense-space-data-network-golden-dome.md @@ -7,9 +7,12 @@ date: 2026-03-01 domain: space-development secondary_domains: [] format: thread -status: unprocessed +status: processed +processed_by: astra +processed_date: 2026-04-03 priority: medium tags: [Golden-Dome, Space-Data-Network, SDN, PWSA, SDA, defense-demand, AI-battle-management, orbital-compute, Space-Force] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From bd8d0053251ca9f5719eb92cfd89d233b879b1cc Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:17:21 +0000 Subject: [PATCH 13/20] astra: extract claims from 2026-03-27-airandspaceforces-golden-dome-odc-requirement - Source: inbox/queue/2026-03-27-airandspaceforces-golden-dome-odc-requirement.md - Domain: space-development - Claims: 1, Entities: 0 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Astra --- ...ncy-exceeds-interception-decision-windows.md | 17 +++++++++++++++++ 1 file changed, 17 insertions(+) create mode 100644 domains/space-development/golden-dome-missile-defense-requires-orbital-compute-because-ground-transmission-latency-exceeds-interception-decision-windows.md diff --git a/domains/space-development/golden-dome-missile-defense-requires-orbital-compute-because-ground-transmission-latency-exceeds-interception-decision-windows.md b/domains/space-development/golden-dome-missile-defense-requires-orbital-compute-because-ground-transmission-latency-exceeds-interception-decision-windows.md new file mode 100644 index 000000000..bc33aeb8d --- /dev/null +++ b/domains/space-development/golden-dome-missile-defense-requires-orbital-compute-because-ground-transmission-latency-exceeds-interception-decision-windows.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: space-development +description: Space Command official explicitly states on-orbit data centers are architecturally necessary for the $185B Golden Dome program because moving data between ground-based processors and space sensors takes too long for effective missile defense +confidence: experimental +source: "James O'Brien (U.S. Space Command), Air & Space Forces Magazine, March 2026" +created: 2026-04-03 +title: Golden Dome missile defense requires orbital compute because ground-based processing transmission latency exceeds time-critical decision windows for missile interception +agent: astra +scope: causal +sourcer: "Air & Space Forces Magazine" +related_claims: ["[[defense spending is the new catalyst for space investment with US Space Force budget jumping 39 percent in one year to 40 billion]]", "[[governments are transitioning from space system builders to space service buyers which structurally advantages nimble commercial providers]]", "[[space governance gaps are widening not narrowing because technology advances exponentially while institutional design advances linearly]]"] +--- + +# Golden Dome missile defense requires orbital compute because ground-based processing transmission latency exceeds time-critical decision windows for missile interception + +James O'Brien, chief of U.S. Space Command's global satellite communications and spectrum division, stated 'I can't see it without it' when asked whether space-based compute will be required for Golden Dome. The operational logic is specific: data latency between sensors and decision makers limits response time in missile defense scenarios where seconds matter. On-orbit data centers shift compute requirements from ground to space, putting processing power physically closer to spacecraft and reducing transmission latency. This creates faster tactical decision-making in time-critical interception scenarios. The statement is notable for its directness—not hedged language about future possibilities, but present-tense architectural requirement for an active $185B program (recently increased by $10B to expand space-based sensors and data systems). The U.S. Space Force has allocated $500M for orbital computing research through 2027, indicating this is not speculative but an operational requirement driving procurement. This establishes defense as the first named anchor customer category for orbital AI data centers, with a specific technical rationale (latency reduction for time-critical decisions) rather than general compute demand. -- 2.45.2 From f1476495c6343f16c40a50289629328d47f908e1 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:20:20 +0000 Subject: [PATCH 14/20] =?UTF-8?q?source:=202026-04-02-techcrunch-aetherflu?= =?UTF-8?q?x-sbsp-dod-funding-falcon9-demo.md=20=E2=86=92=20processed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- ...02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/space-development}/2026-04-02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md (98%) diff --git a/inbox/queue/2026-04-02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md b/inbox/archive/space-development/2026-04-02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md similarity index 98% rename from inbox/queue/2026-04-02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md rename to inbox/archive/space-development/2026-04-02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md index 366a69a2a..5bcf57ef3 100644 --- a/inbox/queue/2026-04-02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md +++ b/inbox/archive/space-development/2026-04-02-techcrunch-aetherflux-sbsp-dod-funding-falcon9-demo.md @@ -7,9 +7,12 @@ date: 2025-04-02 domain: space-development secondary_domains: [energy] format: thread -status: unprocessed +status: processed +processed_by: astra +processed_date: 2026-04-03 priority: medium tags: [Aetherflux, SBSP, space-based-solar-power, DoD-funding, Falcon9, Apex-bus, ODC, Galactic-Brain, dual-use, defense-demand] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From bc26555fdb7eb07503885d376609d4d6e9865e01 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:19:06 +0000 Subject: [PATCH 15/20] astra: extract claims from 2026-03-xx-breakingdefense-space-data-network-golden-dome - Source: inbox/queue/2026-03-xx-breakingdefense-space-data-network-golden-dome.md - Domain: space-development - Claims: 2, Entities: 2 - Enrichments: 1 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Astra --- ...orbital-compute-for-latency-constraints.md | 17 +++++++++ ...creates-dual-use-orbital-infrastructure.md | 17 +++++++++ entities/space-development/aalyria.md | 22 ++++++++++++ .../space-development/space-data-network.md | 36 +++++++++++++++++++ 4 files changed, 92 insertions(+) create mode 100644 domains/space-development/golden-dome-space-data-network-requires-orbital-compute-for-latency-constraints.md create mode 100644 domains/space-development/military-commercial-space-architecture-convergence-creates-dual-use-orbital-infrastructure.md create mode 100644 entities/space-development/aalyria.md create mode 100644 entities/space-development/space-data-network.md diff --git a/domains/space-development/golden-dome-space-data-network-requires-orbital-compute-for-latency-constraints.md b/domains/space-development/golden-dome-space-data-network-requires-orbital-compute-for-latency-constraints.md new file mode 100644 index 000000000..0d5e84e32 --- /dev/null +++ b/domains/space-development/golden-dome-space-data-network-requires-orbital-compute-for-latency-constraints.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: space-development +description: The SDN's real-time target tracking requirement for missile defense creates a technical necessity for on-orbit compute, not merely a preference +confidence: likely +source: Breaking Defense, March 2026; SDA PWSA program description +created: 2026-04-03 +title: Golden Dome's Space Data Network requires distributed orbital data processing because sensor-to-shooter missile defense latency constraints make ground-based processing architecturally infeasible +agent: astra +scope: structural +sourcer: Breaking Defense +related_claims: ["[[defense spending is the new catalyst for space investment with US Space Force budget jumping 39 percent in one year to 40 billion]]"] +--- + +# Golden Dome's Space Data Network requires distributed orbital data processing because sensor-to-shooter missile defense latency constraints make ground-based processing architecturally infeasible + +The Pentagon's Space Data Network (SDN) is designed as a multi-orbit hybrid architecture integrating military and commercial satellites to provide 'sensor-to-shooter' connectivity for Golden Dome missile defense. The SDA's Proliferated Warfighter Space Architecture (PWSA) is explicitly described as 'a prerequisite for the modern Golden Dome program' and 'would rely on space-based data processing to continuously track targets.' This is not a design choice but a latency constraint: missile defense requires processing sensor data and directing interceptors in near-real time (seconds), which is incompatible with the round-trip latency of transmitting raw sensor data to ground stations, processing it, and transmitting targeting commands back to space-based interceptors. The architecture is described as 'in essence a space-based internet' of interlinked satellites across multiple orbits, which is structurally identical to commercial orbital data center architectures. The Air Force Research Laboratory is already funding AI startups like Aalyria for SDN network orchestration, indicating the procurement pipeline has moved from stated requirement to funded R&D contracts. This establishes orbital compute as a technical necessity for the $185 billion (official) to $3.6 trillion (independent estimate) Golden Dome program. diff --git a/domains/space-development/military-commercial-space-architecture-convergence-creates-dual-use-orbital-infrastructure.md b/domains/space-development/military-commercial-space-architecture-convergence-creates-dual-use-orbital-infrastructure.md new file mode 100644 index 000000000..95ad91bea --- /dev/null +++ b/domains/space-development/military-commercial-space-architecture-convergence-creates-dual-use-orbital-infrastructure.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: space-development +description: The SDN 'space-based internet' architecture is technically identical to commercial ODC designs, creating dual-use infrastructure opportunities +confidence: experimental +source: Breaking Defense SDN architecture description; Axiom/Kepler SDA Tranche 1 compatibility +created: 2026-04-03 +title: Military and commercial space architectures are converging on the same distributed orbital compute design because both require low-latency data processing across multi-orbit satellite networks +agent: astra +scope: structural +sourcer: Breaking Defense +related_claims: ["[[defense spending is the new catalyst for space investment with US Space Force budget jumping 39 percent in one year to 40 billion]]", "[[governments are transitioning from space system builders to space service buyers which structurally advantages nimble commercial providers]]"] +--- + +# Military and commercial space architectures are converging on the same distributed orbital compute design because both require low-latency data processing across multi-orbit satellite networks + +The Space Data Network is explicitly framed as 'a space-based internet' comprising interlinked satellites across multiple orbits with distributed data processing capabilities. This architecture is structurally identical to what commercial orbital data center operators are building: compute nodes in various orbits connected by high-speed inter-satellite links. The convergence is not coincidental—both military and commercial use cases face the same fundamental constraint: latency-sensitive applications (missile defense for military, real-time Earth observation analytics for commercial) cannot tolerate ground-based processing delays. The SDN is designed as a 'hybrid' architecture explicitly incorporating both classified military and unclassified commercial communications satellites, indicating the Pentagon recognizes it cannot build this infrastructure in isolation. Commercial ODC operators like Axiom and Kepler are already building to SDA Tranche 1 standards, demonstrating technical compatibility. This creates a dual-use infrastructure dynamic where military requirements drive initial architecture development and procurement funding, while commercial operators can serve both markets with the same underlying technology platform. diff --git a/entities/space-development/aalyria.md b/entities/space-development/aalyria.md new file mode 100644 index 000000000..096152d09 --- /dev/null +++ b/entities/space-development/aalyria.md @@ -0,0 +1,22 @@ +# Aalyria + +**Type:** Company +**Domain:** Space Development +**Focus:** AI-enabled space network orchestration +**Location:** California, USA + +## Overview + +Aalyria is a California-based startup developing AI capabilities for space network orchestration. The company was selected by the Air Force Research Laboratory's Rapid Architecture Prototyping and Integration Development (RAPID) unit to support the Space Data Network Experimentation program. + +## Timeline + +- **2026-03** — Awarded AFRL RAPID contract to support Space Data Network Experimentation program, providing AI capabilities for network orchestration in support of the Pentagon's Space Data Network architecture for Golden Dome missile defense + +## Significance + +Aalyria represents the first documented case of AFRL contracting AI startups specifically for Space Data Network orchestration, indicating the defense procurement pipeline for orbital compute-adjacent technologies is moving from stated requirements to funded R&D contracts. + +## Sources + +- Breaking Defense, March 2026: Pentagon's Space Data Network architecture \ No newline at end of file diff --git a/entities/space-development/space-data-network.md b/entities/space-development/space-data-network.md new file mode 100644 index 000000000..6d653e7a7 --- /dev/null +++ b/entities/space-development/space-data-network.md @@ -0,0 +1,36 @@ +# Space Data Network (SDN) + +**Type:** Protocol/Architecture +**Domain:** Space Development +**Sponsor:** U.S. Space Force, Air Force Research Laboratory +**Status:** Active development + +## Overview + +The Space Data Network (SDN) is the Pentagon's multi-orbit satellite communications architecture designed to provide real-time sensor-to-shooter connectivity for the Golden Dome missile defense system. The SDN is envisioned as "a space-based internet" integrating classified military and unclassified commercial communications satellites with missile warning/tracking sensors, GPS satellites, and distributed data processing capabilities. + +## Architecture + +The SDN comprises: +- Multi-orbit hybrid satellite constellation (military and commercial) +- Interlinked communications satellites across orbits +- Missile warning and tracking sensors +- Position, navigation, and timing (GPS) satellites +- Distributed on-orbit data processing nodes +- AI-enabled network orchestration + +## Relationship to Golden Dome + +The SDA's Proliferated Warfighter Space Architecture (PWSA) is described as "a prerequisite for the modern Golden Dome program." The PWSA "would rely on space-based data processing to continuously track targets," establishing orbital compute as a technical requirement rather than a design preference. + +## Timeline + +- **2026-03** — Breaking Defense reports SDN architecture details; AFRL contracts Aalyria for AI-enabled network orchestration capabilities; Golden Dome budget increases by $10B to $185B to expand space-based sensors and data systems + +## Significance + +The SDN represents the clearest technical specification of why Golden Dome requires orbital data processing: sensor-to-shooter latency constraints for missile defense make ground-based processing architecturally infeasible. The architecture is structurally identical to commercial orbital data center designs, creating potential for dual-use infrastructure. + +## Sources + +- Breaking Defense, March 2026: Pentagon's Space Data Network architecture \ No newline at end of file -- 2.45.2 From e91ecb5645f5598a6766a4ce7060258758a288a0 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:21:05 +0000 Subject: [PATCH 16/20] =?UTF-8?q?source:=202026-04-03-coe-ai-framework-con?= =?UTF-8?q?vention-scope-stratification.md=20=E2=86=92=20processed?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- ...04-03-coe-ai-framework-convention-scope-stratification.md | 5 ++++- 1 file changed, 4 insertions(+), 1 deletion(-) rename inbox/{queue => archive/grand-strategy}/2026-04-03-coe-ai-framework-convention-scope-stratification.md (98%) diff --git a/inbox/queue/2026-04-03-coe-ai-framework-convention-scope-stratification.md b/inbox/archive/grand-strategy/2026-04-03-coe-ai-framework-convention-scope-stratification.md similarity index 98% rename from inbox/queue/2026-04-03-coe-ai-framework-convention-scope-stratification.md rename to inbox/archive/grand-strategy/2026-04-03-coe-ai-framework-convention-scope-stratification.md index 240e33876..f47cdbf98 100644 --- a/inbox/queue/2026-04-03-coe-ai-framework-convention-scope-stratification.md +++ b/inbox/archive/grand-strategy/2026-04-03-coe-ai-framework-convention-scope-stratification.md @@ -7,10 +7,13 @@ date: 2026-04-03 domain: grand-strategy secondary_domains: [ai-alignment] format: research-synthesis -status: unprocessed +status: processed +processed_by: leo +processed_date: 2026-04-03 priority: high tags: [council-of-europe, ai-governance, international-treaty, scope-stratification, national-security-carve-out, legislative-ceiling] flagged_for_theseus: ["First binding international AI treaty — implications for RSP adequacy and Layer 0 governance architecture error analysis"] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From 583cd18c04b375eda3d6190496a8e70fa29baf5b Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:22:08 +0000 Subject: [PATCH 17/20] entity-batch: update 1 entities - Applied 1 entity operations from queue - Files: domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA> --- ...cular-risk-creating-efficacy-translation-barrier.md | 10 ++++++++++ 1 file changed, 10 insertions(+) diff --git a/domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md b/domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md index ad9c946ae..4d6f1f14a 100644 --- a/domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md +++ b/domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md @@ -10,6 +10,16 @@ agent: vida scope: structural sourcer: Institute for Clinical and Economic Review (ICER) related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]"] + +### Auto-enrichment (near-duplicate conversion, similarity=1.00) +*Source: PR #2290 — "glp1 access inverted by cardiovascular risk creating efficacy translation barrier"* +*Auto-converted by substantive fixer. Review: revert if this evidence doesn't belong here.* + +### Additional Evidence (confirm) +*Source: [[2026-02-01-lancet-making-obesity-treatment-more-equitable]] | Added: 2026-04-03* + +The Lancet February 2026 editorial provides highest-prestige institutional framing of the access inversion problem: 'populations with highest obesity prevalence and cardiometabolic risk (lower income, Black Americans, rural) face the highest access barriers' due to Medicare Part D weight-loss exclusion, limited Medicaid coverage, and high list prices. Frames this as structural policy failure, not market failure—'the market is functioning as designed; the design is wrong.' + --- # GLP-1 anti-obesity drug access is structurally inverted: populations with greatest cardiovascular mortality risk face the highest costs and lowest coverage rates, preventing clinical efficacy from reaching population-level impact -- 2.45.2 From 4cafc83519d75e60706567a4398931f858af859c Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:22:24 +0000 Subject: [PATCH 18/20] =?UTF-8?q?source:=202026-04-03-nasaspaceflight-ng3-?= =?UTF-8?q?net-april12.md=20=E2=86=92=20null-result?= MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Pentagon-Agent: Epimetheus --- .../2026-04-03-nasaspaceflight-ng3-net-april12.md | 3 ++- 1 file changed, 2 insertions(+), 1 deletion(-) rename inbox/{queue => null-result}/2026-04-03-nasaspaceflight-ng3-net-april12.md (98%) diff --git a/inbox/queue/2026-04-03-nasaspaceflight-ng3-net-april12.md b/inbox/null-result/2026-04-03-nasaspaceflight-ng3-net-april12.md similarity index 98% rename from inbox/queue/2026-04-03-nasaspaceflight-ng3-net-april12.md rename to inbox/null-result/2026-04-03-nasaspaceflight-ng3-net-april12.md index 1cf678d1d..9056660fd 100644 --- a/inbox/queue/2026-04-03-nasaspaceflight-ng3-net-april12.md +++ b/inbox/null-result/2026-04-03-nasaspaceflight-ng3-net-april12.md @@ -7,9 +7,10 @@ date: 2026-04-03 domain: space-development secondary_domains: [] format: thread -status: unprocessed +status: null-result priority: high tags: [New-Glenn, NG-3, Blue-Origin, booster-reuse, AST-SpaceMobile, BlueBird, launch-window, Pattern-2] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content -- 2.45.2 From a1c26fba70e4c3ccd827cb810089004b8c9576ee Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:21:02 +0000 Subject: [PATCH 19/20] leo: extract claims from 2026-04-03-coe-ai-framework-convention-scope-stratification - Source: inbox/queue/2026-04-03-coe-ai-framework-convention-scope-stratification.md - Domain: grand-strategy - Claims: 1, Entities: 1 - Enrichments: 3 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Leo --- ...tion-excluding-high-stakes-applications.md | 17 +++++++ ...uncil-of-europe-ai-framework-convention.md | 49 +++++++++++++++++++ 2 files changed, 66 insertions(+) create mode 100644 domains/grand-strategy/binding-international-ai-governance-achieves-legal-form-through-scope-stratification-excluding-high-stakes-applications.md create mode 100644 entities/grand-strategy/council-of-europe-ai-framework-convention.md diff --git a/domains/grand-strategy/binding-international-ai-governance-achieves-legal-form-through-scope-stratification-excluding-high-stakes-applications.md b/domains/grand-strategy/binding-international-ai-governance-achieves-legal-form-through-scope-stratification-excluding-high-stakes-applications.md new file mode 100644 index 000000000..b0ac0cd6b --- /dev/null +++ b/domains/grand-strategy/binding-international-ai-governance-achieves-legal-form-through-scope-stratification-excluding-high-stakes-applications.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: grand-strategy +description: The first binding international AI treaty confirms that governance frameworks achieve binding status by scoping out the applications that most require governance, creating a two-tier architecture where civil applications are governed but military, frontier, and private sector AI remain unregulated +confidence: experimental +source: Council of Europe Framework Convention on AI (CETS 225), entered force November 2025; civil society critiques; GPPi policy brief March 2026 +created: 2026-04-03 +title: Binding international AI governance achieves legal form through scope stratification — the Council of Europe AI Framework Convention entered force by explicitly excluding national security, defense applications, and making private sector obligations optional +agent: leo +scope: structural +sourcer: Council of Europe, civil society organizations, GPPi +related_claims: ["eu-ai-act-article-2-3-national-security-exclusion-confirms-legislative-ceiling-is-cross-jurisdictional.md", "the-legislative-ceiling-on-military-ai-governance-is-conditional-not-absolute-cwc-proves-binding-governance-without-carveouts-is-achievable-but-requires-three-currently-absent-conditions.md", "international-ai-governance-stepping-stone-theory-fails-because-strategic-actors-opt-out-at-non-binding-stage.md"] +--- + +# Binding international AI governance achieves legal form through scope stratification — the Council of Europe AI Framework Convention entered force by explicitly excluding national security, defense applications, and making private sector obligations optional + +The Council of Europe AI Framework Convention (CETS 225) entered into force on November 1, 2025, becoming the first legally binding international AI treaty. However, it achieved this binding status through systematic exclusion of high-stakes applications: (1) National security activities are completely exempt — parties 'are not required to apply the provisions of the treaty to activities related to the protection of their national security interests'; (2) National defense matters are explicitly excluded; (3) Private sector obligations are opt-in — parties may choose whether to directly obligate companies or 'take other measures' while respecting international obligations. Civil society organizations warned that 'the prospect of failing to address private companies while also providing states with a broad national security exemption would provide little meaningful protection to individuals who are increasingly subject to powerful AI systems.' This pattern mirrors the EU AI Act Article 2.3 national security carve-out, suggesting scope stratification is the dominant mechanism by which AI governance frameworks achieve binding legal form. The treaty's rapid entry into force (18 months from adoption, requiring only 5 ratifications including 3 CoE members) was enabled by its limited scope — it binds only where it excludes the highest-stakes AI deployments. This creates a two-tier international architecture: Tier 1 (CoE treaty) binds civil AI applications with minimal enforcement; Tier 2 (military, frontier development, private sector) remains ungoverned internationally. The GPPi March 2026 policy brief 'Anchoring Global AI Governance' acknowledges the challenge of building on this foundation given its structural limitations. diff --git a/entities/grand-strategy/council-of-europe-ai-framework-convention.md b/entities/grand-strategy/council-of-europe-ai-framework-convention.md new file mode 100644 index 000000000..f39850978 --- /dev/null +++ b/entities/grand-strategy/council-of-europe-ai-framework-convention.md @@ -0,0 +1,49 @@ +# Council of Europe AI Framework Convention (CETS 225) + +**Type:** International treaty +**Status:** In force (November 1, 2025) +**Formal title:** Framework Convention on Artificial Intelligence and Human Rights, Democracy and the Rule of Law +**Scope:** Civil AI applications (excludes national security, defense, and makes private sector obligations optional) + +## Overview + +The first legally binding international AI treaty, adopted by the Council of Europe Committee of Ministers on May 17, 2024, and entered into force on November 1, 2025, after five ratifications including three CoE member states. + +## Key Provisions + +**Scope exclusions:** +- National security activities: Complete exemption — parties not required to apply treaty provisions +- National defense: Explicitly excluded +- Research and development: Excluded except when testing may interfere with human rights, democracy, or rule of law +- Private sector: Opt-in obligations — parties may choose direct obligations or alternative measures + +**Signatories:** +- EU Commission (signed) +- United States (signed September 2024 under Biden, ratification unlikely under Trump) +- UK, France, Norway (among ratifying states) +- China: Did not participate in negotiations + +## Timeline + +- **2024-05-17** — Adopted by Committee of Ministers +- **2024-09-05** — Opened for signature in Vilnius +- **2024-09** — United States signed under Biden administration +- **2025-11-01** — Entered into force after five ratifications +- **2026-03** — GPPi policy brief acknowledges challenges of building on treaty given structural scope limitations + +## Civil Society Response + +Organizations warned that failing to address private companies while providing broad national security exemptions would provide 'little meaningful protection to individuals who are increasingly subject to powerful AI systems prone to bias, human manipulation, and the destabilisation of democratic institutions.' + +## Governance Architecture + +Creates two-tier international AI governance: +- **Tier 1:** Civil AI applications (bound by treaty, minimal enforcement) +- **Tier 2:** Military, national security, frontier development, private sector (ungoverned internationally) + +## Sources + +- Council of Europe official documentation +- CETaS Turing Institute analysis +- GPPi policy brief (March 2026): "Anchoring Global AI Governance" +- Civil society critiques \ No newline at end of file -- 2.45.2 From 495623ff1b03ab8f1515fd58f1b7a6af3596a5c1 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Fri, 3 Apr 2026 14:11:35 +0000 Subject: [PATCH 20/20] vida: extract claims from 2025-10-xx-california-ab489-ai-healthcare-disclosure-2026 - Source: inbox/queue/2025-10-xx-california-ab489-ai-healthcare-disclosure-2026.md - Domain: health - Claims: 1, Entities: 0 - Enrichments: 1 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida --- ...d-by-fda-enforcement-discretion-expansion.md | 17 +++++++++++++++++ 1 file changed, 17 insertions(+) create mode 100644 domains/health/state-clinical-ai-disclosure-laws-fill-federal-regulatory-gap-created-by-fda-enforcement-discretion-expansion.md diff --git a/domains/health/state-clinical-ai-disclosure-laws-fill-federal-regulatory-gap-created-by-fda-enforcement-discretion-expansion.md b/domains/health/state-clinical-ai-disclosure-laws-fill-federal-regulatory-gap-created-by-fda-enforcement-discretion-expansion.md new file mode 100644 index 000000000..173fe6452 --- /dev/null +++ b/domains/health/state-clinical-ai-disclosure-laws-fill-federal-regulatory-gap-created-by-fda-enforcement-discretion-expansion.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: Documents divergent regulatory trajectories where states build consumer protections in the exact space federal regulation vacated +confidence: experimental +source: Hintze Law analysis of California AB 3030 (effective Jan 2025) and AB 489 (effective Jan 2026), Colorado and Utah parallel legislation, FDA January 2026 CDS guidance +created: 2026-04-03 +title: State clinical AI disclosure laws fill a federal regulatory gap created by FDA enforcement discretion expansion because California Colorado and Utah enacted patient notification requirements while FDA's January 2026 CDS guidance expanded enforcement discretion without adding disclosure mandates +agent: vida +scope: structural +sourcer: Hintze Law / Medical Board of California +related_claims: ["[[healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software]]"] +--- + +# State clinical AI disclosure laws fill a federal regulatory gap created by FDA enforcement discretion expansion because California Colorado and Utah enacted patient notification requirements while FDA's January 2026 CDS guidance expanded enforcement discretion without adding disclosure mandates + +California enacted two sequential clinical AI laws: AB 3030 (effective January 1, 2025) requires health facilities to notify patients when using generative AI to communicate clinical information and provide instructions for human contact; AB 489 (effective January 1, 2026) prohibits AI from misrepresenting itself as a licensed healthcare provider. Colorado and Utah enacted similar disclosure requirements. This state-level regulatory innovation operates in the exact space that federal regulation vacated: the FDA's January 2026 CDS guidance expanded enforcement discretion for clinical decision support tools but contains NO disclosure requirements for AI clinical tools. The federal regulatory track is entirely absent on the patient notification dimension. Notably, no federal legislation following California's model has emerged in Congress as of 2026, breaking the historical pattern where California state law (HIPAA, ACA) influenced subsequent federal legislation. The result is a state-federal regulatory divergence creating inconsistent patient protections depending on state of residence: patients in California, Colorado, and Utah receive mandatory disclosure of AI use in clinical communications; patients in other states do not. This divergence is structural rather than temporary because the FDA explicitly chose NOT to add disclosure requirements when expanding enforcement discretion, and Congress has not moved to fill the gap. -- 2.45.2